Gleason Shane Thomas's Form 4 filing
InspireMD, Inc.NSPR · filed May 21, 2026
- Accession no.
- 0001493152-26-024864
- Filed
- May 21, 2026
- Trade date
- Jan 27, 2025-May 19, 2026
- Filing delay
- 479 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 14 non-derivative transactions. Open-market sales total $189.6K. It was filed 479 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gleason Shane ThomasCIK 0001966214 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 27, 2025 | Common Stock | SSaleDisposed | −3,858 | $2.71 | −$10,455.18 | 1,135,319 | Direct | |
| Jan 28, 2025 | Common Stock | SSaleDisposed | −2,476 | $2.61 | −$6,462.36 | 1,132,843 | Direct | |
| Jan 29, 2025 | Common Stock | SSaleDisposed | −3,660 | $2.46 | −$9,003.6 | 1,129,183 | Direct | |
| Jan 30, 2025 | Common Stock | SSaleDisposed | −2,454 | $2.51 | −$6,159.54 | 1,126,729 | Direct | |
| Jan 31, 2025 | Common Stock | SSaleDisposed | −9,923 | $2.55 | −$25,303.65 | 1,116,806 | Direct | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −7,073 | $2.51 | −$17,753.23 | 1,109,733 | Direct | |
| Feb 4, 2025 | Common Stock | SSaleDisposed | −5,132 | $2.46 | −$12,624.72 | 1,104,601 | Direct | |
| Feb 25, 2025 | Common Stock | SSaleDisposed | −10,000 | $3.65 | −$36,500 | 1,094,601 | Direct | |
| May 23, 2025 | Common Stock | SSaleDisposed | −2,482 | $2.51 | −$6,229.82 | 1,092,119 | Direct | |
| May 27, 2025 | Common Stock | SSaleDisposed | −1,572 | $2.51 | −$3,945.72 | 1,090,547 | Direct | |
| May 29, 2025 | Common Stock | SSaleDisposed | −3,760 | $2.51 | −$9,437.6 | 1,086,787 | Direct | |
| May 30, 2025 | Common Stock | SSaleDisposed | −7,186 | $2.51 | −$18,036.86 | 1,079,601 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −2,941 | $1.59 | −$4,676.19 | 1,076,660 | Direct | |
| May 19, 2026 | Common Stock | SSaleDisposed | −22,778 | $1.01F2 | −$23,005.78 | 1,053,882 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $1.00 to $1.04. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Referenced by the price of 1 transaction in Table I.